...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: no bids or asks on the TD plat this morn?? - anyone seeing anything?

Thanks for the correction Old Timer, my point was ZCC is a reporting company.

tada 

Share
New Message
Please login to post a reply